US Stock MarketDetailed Quotes

TOVX Theriva Biologics

Watchlist
  • 1.5900
  • -0.0600-3.64%
Close Jan 3 16:00 ET
  • 1.6000
  • +0.0100+0.63%
Post 20:01 ET
4.42MMarket Cap-0.05P/E (TTM)

Theriva Biologics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities
-32.51%-3.91M
11.31%-3.45M
12.99%-4.88M
0.45%-19M
-21.85%-6.54M
33.73%-2.95M
10.65%-3.89M
-14.44%-5.61M
-48.04%-19.08M
-11.60%-5.37M
Net income from continuing operations
-134.02%-7.73M
-63.54%-8.32M
-15.34%-5.17M
6.79%-18.35M
14.90%-5.49M
26.48%-3.3M
-13.58%-5.09M
-4.80%-4.48M
-37.97%-19.69M
-22.46%-6.45M
Depreciation and amortization
3.13%33K
18.75%38K
21.88%39K
58.82%135K
56.00%39K
33.33%32K
77.78%32K
77.78%32K
-2.30%85K
92.31%25K
Deferred tax
57.31%-225K
38.44%-221K
32.42%-223K
-15.09%-1.64M
24.01%-424K
-57.31%-527K
32.52%-359K
---330K
---1.43M
---558K
Other non cash items
149.35%723K
-134.59%-184K
42.86%310K
-188.08%-2M
-154.05%-1.29M
-697.96%-1.47M
234.01%532K
382.22%217K
1,269.88%2.27M
--2.38M
Change In working capital
-88.36%253K
17.70%991K
99.83%-2K
386.48%2.31M
152.33%471K
10,447.62%2.17M
-8.38%842K
-46.39%-1.18M
-213.68%-806K
-652.15%-900K
-Change in prepaid assets
-92.45%107K
-49.60%252K
271.36%766K
461.98%1.31M
86.35%-156K
440.84%1.42M
290.63%500K
-214.62%-447K
-308.62%-363K
-929.73%-1.14M
-Change in payables and accrued expense
-68.83%269K
91.95%858K
-3.65%-653K
544.20%1.42M
207.08%737K
435.80%863K
-46.98%447K
44.98%-630K
-142.48%-319K
-46.07%240K
-Change in other current liabilities
-14.95%-123K
-13.33%-119K
-15.00%-115K
-240.32%-422K
-3,766.67%-110K
-311.54%-107K
-101.92%-105K
-104.08%-100K
42.59%-124K
106.25%3K
Cash from discontinued investing activities
Operating cash flow
-32.51%-3.91M
11.31%-3.45M
12.99%-4.88M
0.45%-19M
-21.85%-6.54M
33.73%-2.95M
10.65%-3.89M
-14.44%-5.61M
-48.04%-19.08M
-11.60%-5.37M
Investing cash flow
Cash flow from continuing investing activities
0
88.89%-1K
0
95.40%-202K
38.46%-56K
-1,072.73%-129K
35.71%-9K
99.81%-8K
-31,300.00%-4.4M
-91K
Net PPE purchase and sale
--0
88.89%-1K
--0
-74.14%-202K
38.46%-56K
-1,072.73%-129K
35.71%-9K
---8K
-728.57%-116K
---91K
Net business purchase and sale
----
----
----
--0
----
----
----
----
---4.28M
--0
Cash from discontinued investing activities
Investing cash flow
--0
88.89%-1K
--0
95.40%-202K
38.46%-56K
-1,072.73%-129K
35.71%-9K
99.81%-8K
-31,300.00%-4.4M
---91K
Financing cash flow
Cash flow from continuing financing activities
371,500.00%3.72M
-16.99%1.77M
0
132.38%625K
55.69%-1.46M
-99.96%1K
2.14M
96.00%-55K
-102.61%-1.93M
-3.29M
Net issuance payments of debt
--0
-235.00%-67K
--0
94.55%-75K
--0
--0
---20K
96.00%-55K
---1.38M
--0
Net common stock issuance
371,500.00%3.72M
----
----
870.49%2.22M
121.53%62K
--1K
----
----
-100.44%-288K
---288K
Net preferred stock issuance
----
----
----
--0
----
----
----
----
--2.73M
--0
Net other financing activities
----
----
----
49.37%-1.52M
----
----
----
----
---3M
----
Cash from discontinued financing activities
Financing cash flow
371,500.00%3.72M
-16.99%1.77M
--0
132.38%625K
55.69%-1.46M
-99.96%1K
--2.14M
96.00%-55K
-102.61%-1.93M
---3.29M
Net cash flow
Beginning cash position
-51.40%16.69M
-49.25%18.36M
-44.42%23.28M
-37.79%41.89M
-38.20%31.26M
-34.40%34.35M
-36.30%36.18M
-37.79%41.88M
981.18%67.33M
-29.88%50.58M
Current changes in cash
93.61%-197K
4.82%-1.68M
13.96%-4.88M
26.90%-18.57M
7.92%-8.05M
-77.78%-3.08M
59.61%-1.77M
46.27%-5.67M
-141.59%-25.41M
-81.85%-8.75M
Effect of exchange rate changes
254.55%17K
119.05%12K
-8.57%-38K
-3.13%-33K
46.15%76K
77.55%-11K
0.00%-63K
-225.00%-35K
---32K
--52K
End cash Position
-47.17%16.51M
-51.40%16.69M
-49.25%18.36M
-44.42%23.28M
-44.42%23.28M
-38.20%31.26M
-34.40%34.35M
-36.30%36.18M
-37.79%41.89M
-37.79%41.89M
Free cash flow
-26.96%-3.91M
11.48%-3.45M
13.12%-4.88M
0.00%-19.2M
-20.85%-6.6M
31.01%-3.08M
10.73%-3.9M
-14.61%-5.62M
-48.78%-19.2M
-13.49%-5.46M
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
--
--
Unqualified Opinion
--
--
--
--
Unqualified Opinion
--
(Q3)Sep 30, 2024 (Q2)Jun 30, 2024 (Q1)Mar 31, 2024 (FY)Dec 31, 2023 (Q4)Dec 31, 2023 (Q3)Sep 30, 2023 (Q2)Jun 30, 2023 (Q1)Mar 31, 2023 (FY)Dec 31, 2022 (Q4)Dec 31, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities -32.51%-3.91M 11.31%-3.45M 12.99%-4.88M 0.45%-19M -21.85%-6.54M 33.73%-2.95M 10.65%-3.89M -14.44%-5.61M -48.04%-19.08M -11.60%-5.37M
Net income from continuing operations -134.02%-7.73M -63.54%-8.32M -15.34%-5.17M 6.79%-18.35M 14.90%-5.49M 26.48%-3.3M -13.58%-5.09M -4.80%-4.48M -37.97%-19.69M -22.46%-6.45M
Depreciation and amortization 3.13%33K 18.75%38K 21.88%39K 58.82%135K 56.00%39K 33.33%32K 77.78%32K 77.78%32K -2.30%85K 92.31%25K
Deferred tax 57.31%-225K 38.44%-221K 32.42%-223K -15.09%-1.64M 24.01%-424K -57.31%-527K 32.52%-359K ---330K ---1.43M ---558K
Other non cash items 149.35%723K -134.59%-184K 42.86%310K -188.08%-2M -154.05%-1.29M -697.96%-1.47M 234.01%532K 382.22%217K 1,269.88%2.27M --2.38M
Change In working capital -88.36%253K 17.70%991K 99.83%-2K 386.48%2.31M 152.33%471K 10,447.62%2.17M -8.38%842K -46.39%-1.18M -213.68%-806K -652.15%-900K
-Change in prepaid assets -92.45%107K -49.60%252K 271.36%766K 461.98%1.31M 86.35%-156K 440.84%1.42M 290.63%500K -214.62%-447K -308.62%-363K -929.73%-1.14M
-Change in payables and accrued expense -68.83%269K 91.95%858K -3.65%-653K 544.20%1.42M 207.08%737K 435.80%863K -46.98%447K 44.98%-630K -142.48%-319K -46.07%240K
-Change in other current liabilities -14.95%-123K -13.33%-119K -15.00%-115K -240.32%-422K -3,766.67%-110K -311.54%-107K -101.92%-105K -104.08%-100K 42.59%-124K 106.25%3K
Cash from discontinued investing activities
Operating cash flow -32.51%-3.91M 11.31%-3.45M 12.99%-4.88M 0.45%-19M -21.85%-6.54M 33.73%-2.95M 10.65%-3.89M -14.44%-5.61M -48.04%-19.08M -11.60%-5.37M
Investing cash flow
Cash flow from continuing investing activities 0 88.89%-1K 0 95.40%-202K 38.46%-56K -1,072.73%-129K 35.71%-9K 99.81%-8K -31,300.00%-4.4M -91K
Net PPE purchase and sale --0 88.89%-1K --0 -74.14%-202K 38.46%-56K -1,072.73%-129K 35.71%-9K ---8K -728.57%-116K ---91K
Net business purchase and sale ---- ---- ---- --0 ---- ---- ---- ---- ---4.28M --0
Cash from discontinued investing activities
Investing cash flow --0 88.89%-1K --0 95.40%-202K 38.46%-56K -1,072.73%-129K 35.71%-9K 99.81%-8K -31,300.00%-4.4M ---91K
Financing cash flow
Cash flow from continuing financing activities 371,500.00%3.72M -16.99%1.77M 0 132.38%625K 55.69%-1.46M -99.96%1K 2.14M 96.00%-55K -102.61%-1.93M -3.29M
Net issuance payments of debt --0 -235.00%-67K --0 94.55%-75K --0 --0 ---20K 96.00%-55K ---1.38M --0
Net common stock issuance 371,500.00%3.72M ---- ---- 870.49%2.22M 121.53%62K --1K ---- ---- -100.44%-288K ---288K
Net preferred stock issuance ---- ---- ---- --0 ---- ---- ---- ---- --2.73M --0
Net other financing activities ---- ---- ---- 49.37%-1.52M ---- ---- ---- ---- ---3M ----
Cash from discontinued financing activities
Financing cash flow 371,500.00%3.72M -16.99%1.77M --0 132.38%625K 55.69%-1.46M -99.96%1K --2.14M 96.00%-55K -102.61%-1.93M ---3.29M
Net cash flow
Beginning cash position -51.40%16.69M -49.25%18.36M -44.42%23.28M -37.79%41.89M -38.20%31.26M -34.40%34.35M -36.30%36.18M -37.79%41.88M 981.18%67.33M -29.88%50.58M
Current changes in cash 93.61%-197K 4.82%-1.68M 13.96%-4.88M 26.90%-18.57M 7.92%-8.05M -77.78%-3.08M 59.61%-1.77M 46.27%-5.67M -141.59%-25.41M -81.85%-8.75M
Effect of exchange rate changes 254.55%17K 119.05%12K -8.57%-38K -3.13%-33K 46.15%76K 77.55%-11K 0.00%-63K -225.00%-35K ---32K --52K
End cash Position -47.17%16.51M -51.40%16.69M -49.25%18.36M -44.42%23.28M -44.42%23.28M -38.20%31.26M -34.40%34.35M -36.30%36.18M -37.79%41.89M -37.79%41.89M
Free cash flow -26.96%-3.91M 11.48%-3.45M 13.12%-4.88M 0.00%-19.2M -20.85%-6.6M 31.01%-3.08M 10.73%-3.9M -14.61%-5.62M -48.78%-19.2M -13.49%-5.46M
Currency Unit USD USD USD USD USD USD USD USD USD USD
Accounting Standards US-GAAP US-GAAP US-GAAP US-GAAP US-GAAP US-GAAP US-GAAP US-GAAP US-GAAP US-GAAP
Audit Opinions -- -- -- Unqualified Opinion -- -- -- -- Unqualified Opinion --
Heat List
US
Overall
Symbol
Price
% Chg

No Data